Cowen initiates Repligen stock with Buy rating, $200 target
TD Cowen began coverage on Repligen Corporation (NASDAQ:RGEN), a prominent bioprocessing company, with a Buy rating and a price target set at $200. The firm highlighted Repligen's strong position for ...
Wells Fargo Sticks to Their Buy Rating for Thermo Fisher (TMO)
In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price ...